Latest Financial Reporting News

Almonty Industries posted a striking turnaround in Q2 2026, driven by soaring tungsten prices, ramping Sangdong Mine operations, and a major $800 million convertible notes raise.

Anteris Technologies posted a $51.7 million loss in H1 2026 amid ramped-up R&D and clinical trial activity, supported by a $320 million capital raise and Medicare reimbursement for its DurAVR heart valve trial.

BNK Banking Corporation is set to book a $3.5 million non-cash goodwill impairment in its FY2026 results, fully writing off its remaining goodwill but leaving capital ratios and cash flow untouched.

Corporate Travel Management (ASX:CTD) has extended its exclusive contract with the UK Ministry of Defence to provide accommodation services for the Afghan Resettlement Programme, with expected transaction values reaching £28 million in the first six months.

News Corp’s FY26 revenue rose 7% to $9.03 billion, driven by Digital Real Estate Services and Dow Jones, while net income from continuing operations increased 15% to $743 million.

Meteoric Resources has secured a secondary listing on the U.S. OTCQB Venture Market, enabling its shares to trade under METOF and enhancing access for U.S. and Brazilian investors without disrupting its ASX presence.

Evolution Mining plans to release its FY26 financial results on 19 August, highlighting 715koz gold and 66kt copper production with robust cash flow and cost metrics.

Etherstack reports a 40% jump in first-half revenue to US$8.5 million, driven by strong trading momentum despite non-recurring expansion expenses. The company projects FY26 revenue between US$17.2 million and US$18.9 million amid ongoing growth initiatives.

Pepper Money, alongside KKR and PIMCO-managed funds, has finalized the $15.4 billion RAMS home loan portfolio acquisition from Westpac, marking a significant step in expanding its capital-light servicing business.

Zelira Therapeutics has raised nearly US$33 million into its HOPE® 1 special purpose vehicle, valuing the SPV at about US$66 million post-money. The funds will advance FDA regulatory submissions and Phase 1 clinical trials for its autism-targeting cannabinoid drug.

EBR Systems has launched the WiSE Coupler in the US, a new accessory designed to improve the implantation of its wireless cardiac pacing electrode. The device has FDA clearance and was piloted in 10 procedures, marking another step in the company’s US commercial expansion.

Change Financial has delivered strong FY26 results with revenue up 21% and underlying EBITDA soaring 17-fold, driven by scaling of its Vertexon PaaS platform and expanding client base.